Skip to content
DraconiticResearch
Search Sources API
186,123 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Engineering a bivalent anti-CsGRP78 nanobody via CDR grafting: in silico design and cytotoxic validation

  • Razieh Malekian Shahreza
  • Azadeh Ebrahim-Habibi
  • Elmira Mohammadi
  • Ali Jahanian-Najafabadi
  • Hamid Bakherad
Open at sourcePDFDOICite

Related

  1. Peptide-Linked Bivalent Nanobody Constructs as Positive Allosteric Modulators of the Calcium-Sensing Receptor.
    Mahdis Nabipour, Charlotte Hagen Skadhauge, Line Juel Rasmussen +3
    Basic & clinical pharmacology & toxicologyPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  2. Artificial Intelligence-Driven Nanobody Engineering for Pathogen Recognition: From Functional Epitope Prioritization to Multimodal Foundation Models
    Rui-Si Hu, Muhammad Ehsan, Wei Luo +5
    BiomoleculesPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMC
  3. Development and Validation of Risk Models for Outcomes of Isolated Coronary Artery Bypass Grafting ― A Nationwide Analysis in Japan ―
    Sachiko Hayashi, Hiraku Kumamaru, Shiori Nishimura +3
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  4. Development and validation of a nomogram for predicting the probability of arthroplasty in patients with osteonecrosis of the femoral head after fibular strut grafting.
    Haitao Zhang, Zequan Luo, Jiayi Zhu +14
    Annals of medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  5. Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer
    Jihong Ma, Dinoop Ravindran Menon, Zhaohui Wang +11
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{shahreza2026engineering,
  title = {{Engineering a bivalent anti-CsGRP78 nanobody via CDR grafting: in silico design and cytotoxic validation}},
  author = {Razieh Malekian Shahreza and Azadeh Ebrahim-Habibi and Elmira Mohammadi and Ali Jahanian-Najafabadi and Hamid Bakherad},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-75601-1},
  url = {https://www.nature.com/articles/s41598-026-75601-1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Engineering a bivalent anti-CsGRP78 nanobody via CDR grafting: in silico design and cytotoxic validation
AU  - Razieh Malekian Shahreza
AU  - Azadeh Ebrahim-Habibi
AU  - Elmira Mohammadi
AU  - Ali Jahanian-Najafabadi
AU  - Hamid Bakherad
PY  - 2026
DA  - 2026/10/12
JO  - Scientific Reports
DO  - 10.1038/s41598-026-75601-1
UR  - https://www.nature.com/articles/s41598-026-75601-1
SN  - 2045-2322
ER  -